IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Checkpoint Capital L.P.

Q2 2026 Holdings

Filed 2026-08-14 | 6 holdings | $389.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$131.7M1,186,00033.8%
Argenx SE(ARGX)SPONSORED ADR04016X101$121.8M131,28331.3%
Revolution Medicines Inc(RVMD)COM76155X100$76.9M410,35319.7%
Cytokinetics Inc(CYTK)COM NEW23282W605$40.5M475,00010.4%
Disc Medicine Inc(IRON)COM254604101$17.6M240,1254.5%
Trevi Therapeutics Inc(TRVI)COM89532M101$1.4M75,0000.4%